Can’t find what you’re looking for? Contact us.

Or, need help ordering? 805.528.4341

Filter Samples By:

Get Weekly Research Sample Updates in your Inbox:

Nonalcoholic steatohepatitis (NASH) Clinical Research Samples

Discovery Life Sciences provides the highest quality Nonalcoholic steatohepatitis (NASH) Clinical Research Samples and Residual Diagnostic Specimens from the Life Science Industry’s only convenient online, open access Biobank. 

  • All Nonalcoholic steatohepatitis (NASH) Sample Orders are Packaged for Delivery within 24 Hours. 
  • All Specimens Ethically Obtained, De-Identified and provided with Highly Annotated Demographic and Clinical Data.
  • Select from an HHS/OHRP Compliant Biorepository following ISBER/BBRB Guidelines.
  • Packaged in Compliance with all UN Regulations (6.2) and U.S. DOT Hazmat regulations. 
Showing 25 of 25 total samples
 (0)
Checkout
Advanced Data View:
Showing 25 of 25 total samples
Buy
Product IDSampleOriginMatrixVial (ml)QuantityPriceAgeGenderEthnicityStorage TempSample DateTest 1Test Data 1Detail 1Test 2Test Data 2Detail 2Test 3Test Data 3Detail 3Product
Details
Price
Buy
Blood TypeCo-morbiditiesConsent Status DateCurrent MedicationsIs PregnantBilirubinLaboratory ResultsRisk GroupEver developed JaundiceLiver BiopsyCirrhosis?Ascites?History of Renal Insufficiency?Abbott Architect
BBS0000-AI900352926103119DDNonalcoholic steatohepatitis (NASH)Serum1.101.00Special Order.
Please Inquire
YMaleNon-Hispanic<-70C31-Oct-19DiagnosisNASHSpecial Order.
Please Inquire
Unknown
BBS0000-AI900352927103019DDNonalcoholic steatohepatitis (NASH)Serum1.101.00Special Order.
Please Inquire
YFemaleNon-Hispanic<-70C30-Oct-19DiagnosisNASHSpecial Order.
Please Inquire
Unknown
BBS0000-AI900358607112019DDNonalcoholic steatohepatitis (NASH)Serum1.101.00$100.00 YMaleNon-Hispanic<-70C20-Nov-19DiagnosisNASHAbbott Architect42 U/LALTAbbott Architect23 U/LAST$100.00Unknown1.2
BBS0000-AI900358608112019DDNonalcoholic steatohepatitis (NASH)Serum1.501.00$100.00 YMaleNon-Hispanic<-70C20-Nov-19DiagnosisNASH$100.00Unknown
BBS0000-CY900356657081419DDNonalcoholic steatohepatitis (NASH)Serum4.002.00$250.00 YMaleNon-Hispanic<-70C14-Aug-19Clinical DiagnosisNonalcoholic steatohepatitis (NASH)CTSlightly nodular liver contour2018-04-30$250.00UnknownCoronary artery disease, Atrial fibrillation, Osteoarthritis, Hypertension2019-08-14Losartan potassium, MeloxicamFalseALT: 21 U/L | AST: 19 U/L | Bilirubin (total): 1.0 mg/dL | Cholesterol: 119 mg/dL | Triglycerides: 78 mg/dL | HDL: 39 mg/dL | LDL: 64 mg/dL | 7-Jun-2018Hyperlipidemia, Obesity, Metabolic syndromeNoYes on 6-Jun-2018 | Steatosis grade 2; Inflammation grade 1; Ballooning grade 1; Fibrosis stage 2NoNoNo
EDP0000-AI900342858100919DDNonalcoholic steatohepatitis (NASH)K2 EDTA Plasma1.201.00$100.00 YFemaleNon-Hispanic<-70C09-Oct-19Abbott Architect | Kinetic W/O Pyridoxal Phosphate34AST$100.00Unknown16 U/L
ALT
1.4
Bilirubin
EDP0000-AI900358876121319DDNonalcoholic steatohepatitis (NASH)K2 EDTA Plasma1.401.00$100.00 YMaleNon-Hispanic<-70C13-Dec-19DiagnosisNASHAbbott Architect5 U/LALTAbbott Architect76 U/LAST$100.00Unknown4.4
EDP0000-CY900085550031319DDNonalcoholic steatohepatitis (NASH)USAK2 EDTA Plasma1.006.00$250.0066 YFemaleNon-Hispanic<-70C13-Mar-19Clinical DiagnosisNASHUltrasoundHepatitic fatty infiltration. No small mass.21-Aug-17$250.00UnknownDiabetes, Hypertension, High cholesterolLovaza, Coreg, MetforminNoNoNo
EDP0000-CY900356515092019DDNonalcoholic steatohepatitis (NASH)K2 EDTA Plasma4.006.00$250.00 YMaleHispanic<-70C20-Sep-19Clinical DiagnosisNonalcoholic steatohepatitis (NASH)UltrasoundHepatic fatty infiltration2016-01-12MRINo focal lesions identified1-Jul-14$250.00UnknownNone2019-09-20NoneFalseNoneObesityNoYes on 5-Feb-2014 | Severe steatosis with associated steatohepatitis, Fibrosis 1 approaching 2NoNoNo
EDP0000-CY900356554101119DDNonalcoholic steatohepatitis (NASH)K2 EDTA Plasma4.002.00$250.00 YFemaleNon-Hispanic<-70C11-Oct-19Clinical DiagnosisNonalcoholic steatohepatitis (NASH)UltrasoundCholecystectomy without obvious cystitis in a patient with fatty liver.2011-02-25CTHepatic Steatosis25-Feb-11$250.00UnknownHyperlipidemia, IBS, Diabetes, Thyroid disease, GERD2019-10-11Lisinopril, Synthroid, Metformin, Pravastatin, Jublia, Ambien, Singulair, HydrochlorothiazideFalseALT: 120 U/L | AST: 90 U/L | Bilirubin (total): 0.7 mg/dL | 22-Jul-2019 | Cholesterol: 158 mg/dL | Triglycerides: 202 mg/dL | HDL: 39 mg/dL | LDL: 79 mg/dL | 24-Jun-2019Hyperlipidemia, Obesity, DiabetesNoYes on 3-Sep-2019 | Stage 2-3NoNoNo
EDP0000-CY900356555101119DDNonalcoholic steatohepatitis (NASH)K2 EDTA Plasma4.002.00$250.00 YMaleNon-Hispanic<-70C11-Oct-19Clinical DiagnosisNonalcoholic steatohepatitis (NASH)UltrasoundHepatomegaly & Hepatic steatosis2018-01-09$250.00UnknownHypertension2019-10-11LosartanFalseALT: 58 U/L | AST: 32 U/L | Bilirubin (total): 1.6 mg/dL | Cholesterol: 166 mg/dL | Triglycerides: 420 mg/dL | HDL: 27 mg/dL | 24-Apr-2019ObesityNoYes on 2-Mar-2018 | Stage F1NoNoNo
EDP0000-CY900356657081419DDNonalcoholic steatohepatitis (NASH)K2 EDTA Plasma4.006.00$250.00 YMaleNon-Hispanic<-70C14-Aug-19Clinical DiagnosisNonalcoholic steatohepatitis (NASH)CTSlightly nodular liver contour2018-04-30$250.00UnknownCoronary artery disease, Atrial fibrillation, Osteoarthritis, Hypertension2019-08-14Losartan potassium, MeloxicamFalseALT: 21 U/L | AST: 19 U/L | Bilirubin (total): 1.0 mg/dL | Cholesterol: 119 mg/dL | Triglycerides: 78 mg/dL | HDL: 39 mg/dL | LDL: 64 mg/dL | 7-Jun-2018Hyperlipidemia, Obesity, Metabolic syndromeNoYes on 6-Jun-2018 | Steatosis grade 2; Inflammation grade 1; Ballooning grade 1; Fibrosis stage 2NoNoNo
LHP0000-AI900112774101819DDNonalcoholic steatohepatitis (NASH)L. Heparin Plasma1.001.00$100.00 YFemaleNon-Hispanic<-70C18-Oct-19DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate17 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate22 U/LAST$100.00Unknown
LHP0000-AI900338335110219DDNonalcoholic steatohepatitis (NASH)L. Heparin Plasma1.201.00$100.00 YFemaleNon-Hispanic<-70C02-Nov-19DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate1221 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate7755 U/LAST$100.00Unknown
LHP0000-AI900338336110719DDNonalcoholic steatohepatitis (NASH)L. Heparin Plasma1.201.00$100.00 YFemaleUnknown<-70C07-Nov-19DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate27 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate23 U/LAST$100.00Unknown
LHP0000-AI900338337110619DDNonalcoholic steatohepatitis (NASH)L. Heparin Plasma1.401.00$100.00 YMaleNon-Hispanic<-70C06-Nov-19DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate27 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate19 U/LAST$100.00Unknown
LHP0000-AI900338563110619DDNonalcoholic steatohepatitis (NASH)L. Heparin Plasma1.101.00$100.00 YMaleNon-Hispanic<-70C06-Nov-19DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate94 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate160 U/LAST$100.00Unknown
LHP0000-AI900352958112219DDNonalcoholic steatohepatitis (NASH)L. Heparin Plasma1.701.00$100.00 YFemaleNon-Hispanic<-70C22-Nov-19DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate14 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate18 U/LAST$100.00Unknown
LHP0000-AI900355310112719DDNonalcoholic steatohepatitis (NASH)L. Heparin Plasma1.101.00$100.00 YFemaleNon-Hispanic<-70C27-Nov-19DiagnosisNASHAbbott Architect | Kinetic W/O Pyridoxal Phosphate39 U/LALTAbbott Architect | Kinetic W/O Pyridoxal Phosphate58 U/LAST$100.00Unknown
LHP0000-AI900358599122019DDNonalcoholic steatohepatitis (NASH)L. Heparin Plasma1.301.00$100.00 YFemaleNon-Hispanic<-70C20-Dec-19DiagnosisNASHAbbott Architect15 U/LALTAbbott Architect15 U/LAST$100.00Unknown0.9
LHP0000-AI900358601121719DDNonalcoholic steatohepatitis (NASH)L. Heparin Plasma1.301.00$100.00 YMaleNon-Hispanic<-70C17-Dec-19DiagnosisNASHAbbott Architect41 U/LALTAbbott Architect152 U/LAST$100.00Unknown4.4
LHP0000-AI900358602121219DDNonalcoholic steatohepatitis (NASH)L. Heparin Plasma1.101.00$100.00 YMaleNon-Hispanic<-70C12-Dec-19DiagnosisNASHAbbott Architect54 U/LALTAbbott Architect130 U/LAST$100.00Unknown13.4
LHP0000-AI900358603121319DDNonalcoholic steatohepatitis (NASH)L. Heparin Plasma1.201.00$100.00 YMaleNon-Hispanic<-70C13-Dec-19DiagnosisNASHAbbott Architect6 U/LALTAbbott Architect130 U/LAST$100.00Unknown12.2
LHP0000-AI900358604121519DDNonalcoholic steatohepatitis (NASH)L. Heparin Plasma1.001.00$100.00 YMaleNon-Hispanic<-70C15-Dec-19DiagnosisNASHAbbott Architect40 U/LALTAbbott Architect73 U/LAST$100.00Unknown6.6
LHP0000-AI900358605121619DDNonalcoholic steatohepatitis (NASH)L. Heparin Plasma1.201.00$100.00 YMaleNon-Hispanic<-70C16-Dec-19DiagnosisNASHAbbott Architect67 U/LALTAbbott Architect35 U/LAST$100.00Unknown8.7

Keep in mind that all the samples comprised in the Research Sample Biobank represent only a small number of the clinical research specimens available through our Discovery Partners™ clinical research programs. If you can’t find the specific sample type, specimen or biofluids you are looking for please make sure to call our client services group at 805.528.4341 - and ask how we can help support your project from resources available at active clinical sites.

Please read carefully before purchasing:

Clinical specimens for research use only.

Transmissible Infectious Risk! May be HIV, HBV and HCV REACTIVE or of unknown infectious agent test status. Materials provided are derived from human blood, tissue and other bio-fluids. Handle all samples as if capable of transmitting infectious agents. Practice good laboratory technique and dispose of in properly marked medical waste.

If you need help searching for a LARGER SAMPLE SET with specific data elements, please contact our Client Services group who can format Excel spreadsheets for a comprehensive review of all available samples: USA (805) 528-4341

These products are supplied without warranty for suitability for specific applications or analytical determinations.

Specimens and data will be may be used for general biomarker research, assay and instrument validation purposes only. All Research products identified as “Diagnostic Remnant Samples” are human biological materials leftover from routine laboratory analysis and are de-identified (coded) to protect subject confidentiality. Under OHRP definition 45 CFR 46.102(f) these coded specimens are not considered subjects for Human research requiring informed consent. Specimens cannot be used for whole genomic sequencing of genetic material. Research products designated as “Clinical Research Samples” by “type” are obtained from IRB approved research study protocols with informed consent obtained from each subject enrolled. Specimens cannot be used for whole genomic sequencing of genetic material.